These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 7285274)

  • 21. Incidence and kinetics of distant metastases in patients with operable breast cancer.
    Kryj M; Maciejewski B; Withers HR; Taylor JM
    Neoplasma; 1997; 44(1):3-11. PubMed ID: 9201274
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinicopathological characteristics of recurrence more than 10 years after surgery in patients with breast carcinoma.
    Takeuchi H; Muto Y; Tashiro H
    Anticancer Res; 2009 Aug; 29(8):3445-8. PubMed ID: 19661371
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Adenoid cystic carcinoma of the head and neck: a review of 30 cases].
    Raux-Rakotomalala F; Houliat T; Martel J; Stoll D; Bébéar JP; Darrouzet V
    Rev Laryngol Otol Rhinol (Bord); 2003; 124(4):235-41. PubMed ID: 15038566
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized phase III comparative trial of immediate consolidation with high-dose chemotherapy and autologous peripheral blood progenitor cell support compared to observation with delayed consolidation in women with metastatic breast cancer and only bone metastases following intensive induction chemotherapy.
    Vredenburgh JJ; Madan B; Coniglio D; Ross M; Broadwater G; Niedzwiecki D; Edwards J; Marks L; Vandemark R; McDonald C; Affronti ML; Peters WP
    Bone Marrow Transplant; 2006 Jun; 37(11):1009-15. PubMed ID: 16633363
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Local recurrence after conservative therapy of breast cancer: risk factors, site of recurrence, evolution].
    Rambert P; Lasry S; Hennebelle F; Des Guetz G; Zhu D; Gentile A; Floiras JL
    Bull Cancer; 1994 Jul; 81(7):616-24. PubMed ID: 7742605
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic factors for patients with liver metastases from breast cancer.
    Eichbaum MH; Kaltwasser M; Bruckner T; de Rossi TM; Schneeweiss A; Sohn C
    Breast Cancer Res Treat; 2006 Mar; 96(1):53-62. PubMed ID: 16319993
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intensified local treatment and systemic therapy significantly increase survival in patients with brain metastases from advanced breast cancer - a retrospective analysis.
    Bartsch R; Fromm S; Rudas M; Wenzel C; Harbauer S; Roessler K; Kitz K; Steger GG; Weitmann HD; Poetter R; Zielinski CC; Dieckmann K
    Radiother Oncol; 2006 Sep; 80(3):313-7. PubMed ID: 16959347
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Survival of patients with metastatic breast carcinoma: importance of prognostic markers of the primary tumor.
    Chang J; Clark GM; Allred DC; Mohsin S; Chamness G; Elledge RM
    Cancer; 2003 Feb; 97(3):545-53. PubMed ID: 12548595
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The amino-terminal propeptide (PINP) of type I collagen is a clinically valid indicator of bone turnover and extent of metastatic spread in osseous metastatic breast cancer.
    Pollmann D; Siepmann S; Geppert R; Wernecke KD; Possinger K; Lüftner D
    Anticancer Res; 2007; 27(4A):1853-62. PubMed ID: 17649784
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduced incidence of distant metastases and lower mortality in 1072 patients with breast cancer with a history of hormone replacement therapy.
    Schuetz F; Diel IJ; Pueschel M; von Holst T; Solomayer EF; Lange S; Sinn P; Bastert G; Sohn C
    Am J Obstet Gynecol; 2007 Apr; 196(4):342.e1-9. PubMed ID: 17403414
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.
    Kim KJ; Huh SJ; Yang JH; Park W; Nam SJ; Kim JH; Lee JH; Kang SS; Lee JE; Kang MK; Park YJ; Nam HR
    Jpn J Clin Oncol; 2005 Mar; 35(3):126-33. PubMed ID: 15741302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Breast cancer prognosis. III. Prognostic factors in patients with distant metastases (M1) at the time of diagnosis.
    Rudan I; Skorić T; Rudan N
    Acta Med Croatica; 1994; 48(4-5):171-4. PubMed ID: 7534519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Brain metastases in breast cancer: prognostic factors and management.
    Lee SS; Ahn JH; Kim MK; Sym SJ; Gong G; Ahn SD; Kim SB; Kim WK
    Breast Cancer Res Treat; 2008 Oct; 111(3):523-30. PubMed ID: 17990100
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact and outcomes of routine microstaging of sentinel lymph nodes in breast cancer: significance of the pN0(i+) and pN1mi categories.
    Pugliese MS; Beatty JD; Tickman RJ; Allison KH; Atwood MK; Szymonifka J; Arthurs ZM; Huynh PP; Dawson JH
    Ann Surg Oncol; 2009 Jan; 16(1):113-20. PubMed ID: 18949520
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential expression of prognostic factors and effect on survival in young (< or =40) breast cancer patients: a case-control study.
    Hartley MC; McKinley BP; Rogers EA; Kalbaugh CA; Messich HS; Blackhurst DW; Lokey JS; Trocha SD
    Am Surg; 2006 Dec; 72(12):1189-94; discussion 1194-5. PubMed ID: 17216817
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
    Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
    BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.
    Chambers SK; Kacinski BM; Ivins CM; Carcangiu ML
    Clin Cancer Res; 1997 Jun; 3(6):999-1007. PubMed ID: 9815777
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Kinetic patterns in the survival of breast cancer patients with recurrence and metastases].
    Maslova IA; Korman DB; Bavli IaL
    Vopr Onkol; 1978; 24(8):69-73. PubMed ID: 695429
    [No Abstract]   [Full Text] [Related]  

  • 39. [Proceedings: Control studies on cytostatic polychemotherapy in 223 patients with metastasizing breast cancer].
    Brunner KW; Martz G; Senn HJ; Obrecht P; Alberto P; Melchert F
    Helv Med Acta; 1974 May; 37(5-6):396-7. PubMed ID: 4410547
    [No Abstract]   [Full Text] [Related]  

  • 40. The place of hypophysectomy in the management of metastatic breast cancer.
    VanGilder JC
    Conn Med; 1975 Jan; 39(1):3-4. PubMed ID: 1109846
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.